Evidence map›Paper›PMID 29437644›Full record

ArticleBMJ (Clinical research ed.)2018

Real world evidence: experience and lessons from China.

Xin Sun, Jing Tan, Li Tang, Jeff Jianfei Guo, Xinling Li

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04214964 (Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China), which is not on this map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04214964 unknown statusnot on this mapstarted 2020, after this paper: background citation

Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study

TypeobservationalSponsorTongji HospitalRan2020 to 2024Enrolled10,000ConditionsGynecologic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Xin SunChinese Evidence-based Medicine Centre and CREAT Group, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China sunx79@hotmail.com.
Jing TanChinese Evidence-based Medicine Centre and CREAT Group, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Li TangChinese Evidence-based Medicine Centre and CREAT Group, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Jeff Jianfei GuoCollege of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA.
Xinling LiCenter for Adverse Drug Reaction Monitoring, Chinese State Food and Drug Administration, Beijing, 100000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Evidence-Based MedicineQuality ImprovementChinaData CollectionHumansResearch Design

Identifiers

PMID29437644
PMCPMC5797980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.